ISRCTN49127736已完成未知
European Randomised study of Screening for Prostate Cancer
Erasmus Medical Centre (Netherlands)0 个研究点目标入组 251,133 人开始时间: 2005年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 251,133
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •Males aged 55 - 74 years (including age 74)
排除标准
- •Previous diagnosis of prostate cancer
研究者
相似试验
招募中
不适用
European Randomized Study of Screening for Prostate Cancer.Prostate cancerNL-OMON29632Prof. dr. F.H. SchröderDept. UrologyErasmus MCP.O. Box 20403000 CA RotterdamThe Netherlandstel. +31-10-463 43 28fax. +31-10-463 39 68E-mail: e.vandenberg@erasmusmc.nl251,133
招募中
3 期
Treatment for Benign Prostatic Hyperplasia, a comparative study between dual pharmacological treatment (Tamsulosin and Finasteride) and a minimally invasive Prostatic Urethral Lift procedure (Urolift)Prostate HyperplasiaRBR-1094jttzniversidade de São Paulo
招募中
Unknown
Prostate Cancer Screening with short, unenhanced Magnetic Resonance ImagingbpMRI of the prostateDRKS00031035Charité Universitätsmedizin Berlin, Klinik für Radiologie900
进行中（未招募）
不适用
Partial prostate Ablation versus Radical Treatment (PART): Comparing partial ablation of the prostate to treatment or removal of the whole prostate in men with localised cancer of one side of the prostate onlyCancerProstate cancerISRCTN17249875niversity of Oxford800
进行中（未招募）
不适用
A Clinical Phase II Study in Patients with Prostate Cancer and Bone Metastases with KML001 (KOMINOX®) - KML001 in patients with prostate cancer and bone metastasesProstate Cancer MetastaticMedDRA version: 8.1Level: LLTClassification code 10036909Term: Prostate cancer metastaticEUCTR2006-005607-33-DEKOMINOX USA, Inc.